What is the CVSS score of CVE-2019-9597?

CVE-2019-9597 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N. EPSS exploitation probability: 1.0%.

Is there a public PoC exploit available for CVE-2019-9597?

Yes, a public proof-of-concept exploit is available for CVE-2019-9597. Prioritise patching immediately. EPSS: 1.0%.

Enterprise Immune System CVE-2019-9597

MEDIUM

Cross-Site Request Forgery (CSRF) (CWE-352)

2019-10-23 cve@mitre.org

CSRF Enterprise Immune System

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

Required

Scope

Unchanged

Confidentiality

None

Integrity

High

Availability

None

Lifecycle Timeline

CVE Published

Oct 23, 2019 - 19:15 nvd

MEDIUM 6.5

DescriptionNVD

Darktrace Enterprise Immune System before 3.1 allows CSRF via the /config endpoint.

AnalysisAI

Darktrace Enterprise Immune System before 3.1 allows CSRF via the /config endpoint. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Cross-Site Request Forgery (CSRF) (CWE-352), which allows attackers to trick authenticated users into performing unintended actions. Darktrace Enterprise Immune System before 3.1 allows CSRF via the /config endpoint. Affected products include: Darktrace Enterprise Immune System. Version information: before 3.1.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Implement anti-CSRF tokens, validate Origin/Referer headers, use SameSite cookie attribute.